Senti Biosciences Holdings, Inc. (SNTI)
About Senti Biosciences Holdings, Inc.
Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $22.0K
- Net income
- -$61.4M
- Total assets
- $51.2M
- Market cap
- $12.6M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $12.6M
- Shares outstanding
- 66.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 9, 2022
Senti Biosciences Holdings, Inc. (SNTI) Stock Price
- Reported a net loss of $61.4M in FY2025.
- Trading 92% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Senti Biosciences Holdings, Inc..
Write a review
News about Senti Biosciences Holdings, Inc.
News & sentiment via Polygon.io
Senti Biosciences Holdings, Inc.: frequently asked questions
Is Senti Biosciences Holdings, Inc. an American company?
Senti Biosciences Holdings, Inc. is a US-based company headquartered in South San Francisco, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Senti Biosciences Holdings, Inc. headquartered?
Senti Biosciences Holdings, Inc. is headquartered in South San Francisco, California, United States.
Is Senti Biosciences Holdings, Inc. publicly traded?
Yes — Senti Biosciences Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol SNTI on the NASDAQ.
What does Senti Biosciences Holdings, Inc. do?
Senti Biosciences Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
